Gavin Spencer - Nicox SA Executive VP of Corporate Devel.
| NICXFDelisted Stock | USD 0.44 0.00 0.00% |
EVP
Dr. Gavin Spencer was Executive Vice President Chief Business Officer and Member of the Management Committee of NicOx SA since 2017. Before that, he was Vice President Business Development at the company. Dr. Spencer was with Nicox since 2005 and was key in building and managing the partnerships, including closing the 2006 Pfizer deal and the 2010 BauschLomb deal. He was responsible for identifying ophthalmology opportunities including the 2012 deal with RPS and his team has led the design and communication of the new Nicox corporate identity since 2017.
| Age | 53 |
| Tenure | 7 years |
| Professional Marks | Ph.D |
| Phone | 33 4 97 24 53 00 |
| Web | https://www.nicox.com |
Nicox SA Management Efficiency
The company has return on total asset (ROA) of (0.0905) % which means that it has lost $0.0905 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.6454) %, meaning that it generated substantial loss on money invested by shareholders. Nicox SA's management efficiency ratios could be used to measure how well Nicox SA manages its routine affairs as well as how well it operates its assets and liabilities.Nicox SA has accumulated 20.52 M in total debt with debt to equity ratio (D/E) of 0.28, which may suggest the company is not taking enough advantage from borrowing. Nicox SA has a current ratio of 5.85, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Nicox SA until it has trouble settling it off, either with new capital or with free cash flow. So, Nicox SA's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nicox SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nicox to invest in growth at high rates of return. When we think about Nicox SA's use of debt, we should always consider it together with cash and equity.
Nicox S.A. operates as an ophthalmology company in France and internationally. The company was founded in 1996 and is headquartered in Valbonne, France. Nicox Sa operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 32 people. Nicox SA [NICXF] is a Pink Sheet which is traded between brokers as part of OTC trading. Management Performance
| Return On Equity | -0.65 | |||
| Return On Asset | -0.0905 |
Nicox SA Leadership Team
Elected by the shareholders, the Nicox SA's board of directors comprises two types of representatives: Nicox SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nicox. The board's role is to monitor Nicox SA's management team and ensure that shareholders' interests are well served. Nicox SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nicox SA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jose Boyer, Consultant | ||
| Michele Garufi, Co-Founder, Chairman and CEO | ||
| Doug Hubatsch, Ex Officer | ||
| Sandrine Gestin, Fin. Director | ||
| Ennio Ongini, Consultant | ||
| MSc MBA, Chief Officer | ||
| Ramesh Krishnamoorthy, Director Control | ||
| Gavin Spencer, Executive VP of Corporate Devel. | ||
| Emmanuelle Pierry, Senior Director of Legal Affairs, Member of the Management Committee |
Nicox Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Nicox SA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.65 | |||
| Return On Asset | -0.0905 | |||
| Operating Margin | (2.29) % | |||
| Current Valuation | 54.64 M | |||
| Shares Outstanding | 50.16 M | |||
| Shares Owned By Insiders | 6.32 % | |||
| Shares Owned By Institutions | 17.02 % | |||
| Price To Earning | 146.39 X | |||
| Price To Book | 0.99 X | |||
| Price To Sales | 5.91 X |
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in Nicox Pink Sheet
If you are still planning to invest in Nicox SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nicox SA's history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Transaction History View history of all your transactions and understand their impact on performance |